CARRIE WEISS: Open Payments
NPI 1114275690 · TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,553 in 143 payments from 21 companies in 2025. Trend: 2023 $194 · 2024 $2,905 · 2025 $3,553
Food & beverage: $3,553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $541 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $529 |
| Janssen Biotech, Inc. | 12 | $488 |
| Madrigal Pharmaceuticals | 7 | $404 |
| Gilead Sciences, Inc. | 13 | $302 |
| Aimmune Therapeutics, Inc. | 9 | $197 |
| Celltrion USA Inc. | 10 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $108 |
| Intercept Pharmaceuticals, Inc. | 5 | $105 |
| PFIZER INC. | 5 | $105 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, RINVOQ, ZENPEP, VEGZELMA, EOHILIA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
